| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
phenotype | 0.620 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 2004 | 2020 | ||||||||
|
transient receptor potential cation channel subfamily A member 1 | 0.546 | 0.846 | 7.2E-35 |
|
phenotype | 0.570 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
phenotype | 0.560 | None | 1.000 | 1 | 0 | 2009 | 2020 | ||||||||
|
kininogen 1 | 0.481 | 0.885 | 3.2E-10 |
|
phenotype | 0.560 | None | 0.958 | 1 | 0 | 1988 | 2019 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
phenotype | 0.540 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
phenotype | 0.540 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
phenotype | 0.520 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
cholecystokinin B receptor | 0.573 | 0.615 | 2.1E-06 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2010 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2012 | ||||||||
|
glial fibrillary acidic protein | 0.421 | 0.885 | 1.5E-06 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2016 | ||||||||
|
mitofusin 2 | 0.471 | 0.846 | 0.99 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2010 | ||||||||
|
calcium/calmodulin dependent protein kinase II alpha | 0.612 | 0.538 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2010 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.270 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
phenotype | 0.250 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
coagulation factor II thrombin receptor | 0.444 | 0.846 | 8.5E-03 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
cathepsin S | 0.539 | 0.731 | 0.34 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2012 | 2017 |